These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. hCAR-EGFP fusion receptor in human follicular lymphoma B cells - a model for adenoviral gene therapy for B cell malignancies. Mättö M; Nuutinen UM; Hakkarainen T; Tallone T; Wahlfors J; Pelkonen J Int J Mol Med; 2006 Jun; 17(6):1057-62. PubMed ID: 16685416 [TBL] [Abstract][Full Text] [Related]
6. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished. van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842 [TBL] [Abstract][Full Text] [Related]
7. Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies. Uusi-Kerttula H; Legut M; Davies J; Jones R; Hudson E; Hanna L; Stanton RJ; Chester JD; Parker AL Hum Gene Ther; 2015 May; 26(5):320-9. PubMed ID: 25919378 [TBL] [Abstract][Full Text] [Related]
8. Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer. Morrison J; Briggs SS; Green NK; Thoma C; Fisher KD; Kehoe S; Seymour LW Hum Gene Ther; 2009 Mar; 20(3):239-51. PubMed ID: 19257852 [TBL] [Abstract][Full Text] [Related]
9. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma. Goebel EA; Davidson BL; Graham SM; Kern JA Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985 [TBL] [Abstract][Full Text] [Related]
10. Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors. Li HJ; Everts M; Yamamoto M; Curiel DT; Herschman HR Cancer Res; 2009 Jan; 69(2):554-64. PubMed ID: 19147569 [TBL] [Abstract][Full Text] [Related]
11. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway. Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777 [TBL] [Abstract][Full Text] [Related]
12. Affilin-based retargeting of adenoviral vectors to the epidermal growth factor receptor. Wienen F; Nilson R; Allmendinger E; Graumann D; Fiedler E; Bosse-Doenecke E; Kochanek S; Krutzke L Biomater Adv; 2023 Jan; 144():213208. PubMed ID: 36442453 [TBL] [Abstract][Full Text] [Related]
13. Unravelling Receptor and RGD Motif Dependence of Retargeted Adenoviral Vectors using Advanced Tumor Model Systems. Chernyavska M; Schmid M; Freitag PC; Palacio-Castañeda V; Piruska A; Huck WTS; Plückthun A; Verdurmen WPR Sci Rep; 2019 Dec; 9(1):18568. PubMed ID: 31811202 [TBL] [Abstract][Full Text] [Related]
14. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems. Kobayashi M; Okada T; Murakami T; Ozawa K; Kobayashi E; Morita T Urology; 2007 Dec; 70(6):1230-6. PubMed ID: 18158067 [TBL] [Abstract][Full Text] [Related]
15. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand. Hoganson DK; Sosnowski BA; Pierce GF; Doukas J Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317 [TBL] [Abstract][Full Text] [Related]
16. Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter. Teimoori-Toolabi L; Azadmanesh K; Amanzadeh A; Zeinali S BioDrugs; 2010 Apr; 24(2):131-46. PubMed ID: 20199127 [TBL] [Abstract][Full Text] [Related]
17. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy. Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer. Wang ZX; Bian HB; Yang JS; De W; Ji XH Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664 [TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. Gu DL; Gonzalez AM; Printz MA; Doukas J; Ying W; D'Andrea M; Hoganson DK; Curiel DT; Douglas JT; Sosnowski BA; Baird A; Aukerman SL; Pierce GF Cancer Res; 1999 Jun; 59(11):2608-14. PubMed ID: 10363982 [TBL] [Abstract][Full Text] [Related]
20. A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens. Buskens CJ; Marsman WA; Wesseling JG; Offerhaus GJ; Yamamoto M; Curiel DT; Bosma PJ; van Lanschot JJ Ann Surg; 2003 Dec; 238(6):815-24; discussion 825-6. PubMed ID: 14631218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]